联环药业：公司他达拉非片可在加纳合法销售

Core Viewpoint - The company has received approval from the Ghana Food and Drug Administration for the registration of Tadalafil tablets (20mg), allowing for legal sales in Ghana [1] Group 1: Product Approval - The approval signifies that Tadalafil tablets (20mg), a PDE5 inhibitor used for treating erectile dysfunction and benign prostatic hyperplasia symptoms, can now be marketed in Ghana [1] - The registration certificate is a crucial step for the company to expand its market presence in West Africa [1] Group 2: Financial Impact - The projected sales revenue for Tadalafil tablets in the fiscal year 2024 is estimated at 23.0793 million RMB [1] - The company anticipates that the approval will not have a significant impact on its recent operating performance [1]